April 2 (Reuters) - U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in ...
The Trump administration imposed new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices. Patented medications ...
1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his investigation into the effects of imports of pharmaceuticals and pharmaceutical ingredients on the national security ...
Iran’s foreign minister, Abbas Araghchi, said on Tuesday that Israel was “openly and unashamedly bombing pharmaceutical companies.” By Parin Behrooz and Ephrat Livni Israeli missiles struck a major ...
Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more than 22,000 employees last year. Among the 17 largest pharma companies ...
A pharmaceutical company has recalled nearly 90,000 bottles of children's ibuprofen for the potential presence of a foreign substance. Strides Pharma, Inc., headquartered in India, has recalled about ...
The life sciences, and in particular, the pharmaceutical supply chain, are far more complex than other products and industries. Pharmaceuticals and other medical products require unique compliance ...
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international ...
On some level, Eli Lilly’s partnership with computing giant Nvidia feels inevitable. The first pharma to reach a $1 trillion valuation teaming up with a tech firm that has ridden the AI wave to a ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — President Trump ...
Merck MRK-3.88%decrease; red down pointing triangle is shaking up the leadership of its main pharmaceutical unit as the U.S. drugmaker braces for sales pressure later this decade. The Rahway, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results